Type 2 Diabetes Patients With Long-Standing Disease Achieved Glycemic Control When BYETTA(R) Was Added to Lantus(R)
Type 2 Diabetes Patients With Long-Standing Disease Achieved Glycemic Control When BYETTA(R) Was Added to Lantus(R)
ORLANDO, Fla., June 26, 2010 /PRNewswire-FirstCall/ — Amylin Pharmaceuticals, Inc.
Read more on redOrbit
